APA (7th ed.) Citation

Mark DeBenedette, Alicia Gamble, Marcus Norris, Joe Horvatinovich, & Charles A. Nicolette. (2023). A review of the clinical experience with CMN-001, a tumor RNA loaded dendritic cell immunotherapy for the treatment of metastatic renal cell carcinoma. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Mark DeBenedette, Alicia Gamble, Marcus Norris, Joe Horvatinovich, and Charles A. Nicolette. A Review of the Clinical Experience with CMN-001, a Tumor RNA Loaded Dendritic Cell Immunotherapy for the Treatment of Metastatic Renal Cell Carcinoma. Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Mark DeBenedette, et al. A Review of the Clinical Experience with CMN-001, a Tumor RNA Loaded Dendritic Cell Immunotherapy for the Treatment of Metastatic Renal Cell Carcinoma. Taylor & Francis Group, 2023.